Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MMP inhibitor-chemotherapeutic drug combination suppresses tumor dissemination in mice

March 5, 1999

MGI-114 in combination with CPT-11 enters clinical evaluation

March 5, 1999

Ontogeny establishes research collaborations for skin cancer therapy

March 5, 1999

Celgene and NCI collaborate on thalidomide study in glioblastoma

March 5, 1999

Australian patent issued for oral form of paclitaxel

March 4, 1999

Epothilone analogue markedly suppresses growth of or cures MDR tumors in vivo

March 3, 1999

Second Ligand/Wyeth-Ayerst SERM to enter clinical trials shortly

March 3, 1999

SuperGen files sNDA for Nipent in mature T-cell malignancies

March 2, 1999

ADIR patents new ellipticine/olivacine derivatives with excellent antitumor activity

March 2, 1999

Onyx and Bayer select lead ras-inhibiting compound

March 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...